Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

122.21 USD +2.43 (+2.03%)
Official Closing Price Updated: 5:40 PM EST, Mar 1, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
75 76 Next >
Electrophysiology Market Value Projected to Exceed $5 Billion by 2022
Financialnewsmedia.com News Commentary 
From PR Newswire
Electrophysiology Market Value Projected to Exceed $5 Billion By 2022
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Abbott and Insulet Partner to Integrate Next-Generation Glucose Sensing and Automated Insulin Delivery Technologies for Seamless Diabetes Care
- Collaboration will combine Abbott's leading continuous glucose monitoring (CGM) technology with Insulet's Omnipod Horizon™ Automated Insulin Delivery System to offer an accurate, easy-to-use,... 
From PR Newswire
Abbott Introduces Next-Generation Heart Rhythm Management Devices in Europe, Featuring State-of-the-Art Patient App and Bluetooth Connectivity
- New Gallant™ high voltage devices offer patients and their doctors a smartphone app and Bluetooth connectivity designed to help doctors tailor therapy to a patient's unique clinical needs 
From PR Newswire
Absolute Receives Application Certification from ServiceNow
Absolute® (TSX:ABT), the leader in endpoint resilience, today announced that it has received certification of its application with ServiceNow®, available in the ServiceNow Store. Certification by... 
From Business Wire News Releases
Global Medical Device Industry Bolstering Outstanding Growth Potentials
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Global Medical Device Industry Bolstering Outstanding Growth Potentials
Financialnewsmedia.com News Commentary 
From PR Newswire
Abbott's In-Development Fully Implantable Heart Pump System Earns FDA's Breakthrough Device Designation
Abbott (NYSE: ABT) today announced that the company has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its in-development Fully Implantable Left... 
From PR Newswire
Absolute Reports Fiscal 2020 Second Quarter Financial Results
Absolute (TSX: ABT) (“Absolute” or the “Company”), the leader in endpoint resilience, today announced its financial results for the three and six months ended December 31, 2019. All dollar figures are... 
From Business Wire News Releases
Abbott Announces First-of-Its-Kind Trial to Assess New Therapy Option for People at Risk of Stroke
- The CATALYST trial will examine Abbott's Amplatzer™ Amulet™ device compared to non-vitamin K oral anticoagulants, the current standard in attempting to lower stroke and bleeding risks for patients... 
From PR Newswire
Jean Boulle Group: European Union Approval for Tendyne Transcatheter Mitral Valve
From ACCESSWIRE
Absolute Extends Power of Resilience to Expanded Ecosystem of Leading Endpoint Security Applications
Absolute® (ABT.TO), the leader in endpoint resilience, today announced the company is extending the power of its Resilience solution and patented Persistence® technology to a growing ecosystem of... 
From Business Wire News Releases
Medical Devices Offer a Boost to Viable and Cost-Effective Treatment Options
FinancialBuzz.com News Commentary 
From PR Newswire
Abbott's Tendyne™ Device Receives World's First CE Mark for Transcatheter Mitral Valve Implantation
- First-of-its-kind technology addresses critical need to eliminate mitral regurgitation when surgery or mitral repair is not an option 
From PR Newswire
Big Changes are Coming to Healthcare Thanks to Augmented Reality
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Big Changes are Coming to Healthcare Thanks to Augmented Reality
Financialnewsmedia.com News Commentary 
From PR Newswire
Abbott Receives Expanded Indication From the U.S. FDA for Directional Deep Brain Stimulation System to Treat Parkinson's Disease
- Abbott's Infinity™ DBS is the first FDA approved directional Deep Brain Stimulation (DBS) system to allow targeting of a specific area of the brain that is critical to motor functions 
From PR Newswire
New Quality of Life and Functional Improvement Data From Abbott's BOLD and TRIUMPH Studies Reinforce Benefit of Proclaim™ XR Neurostimulation System In People Living with Chronic Pain
- BOLD study found that BurstDR™ stimulation waveform reduced the negative psychological effects associated with a person's chronic pain at six-month follow up by 62% 
From PR Newswire
Abbott Reports Fourth-Quarter 2019 Results; Announces Strong Forecast for 2020
- Fourth-quarter sales growth of 7.1 percent; organic sales growth of 8.5 percent 
From PR Newswire
Absolute to Host Conference Call for Fiscal 2020 Second Quarter Financial Results
Absolute (TSX: ABT), the leader in endpoint resilience, today announced it will host a conference call on Monday February 3, at 5:00 p.m. ET (2:00 p.m. PT) to discuss its fiscal 2020 second quarter... 
From Business Wire News Releases
Absolute Declares Quarterly Dividend
Absolute (TSX: ABT) today announced that its Board of Directors has declared a quarterly dividend of CAD$0.08 per share on its common shares, payable in cash on February 28, 2020 to shareholders of... 
From Business Wire News Releases
Absolute Protects Patient Data and Supports HIPAA Compliance for Apria Healthcare
To ensure the highest levels of endpoint security across more than 8,000 devices and to help achieve HIPAA compliance in the face of rising data breaches across the healthcare industry, Apria... 
From Business Wire News Releases
Abbott to Initiate Trial to Study MitraClip as an Option for Moderate Surgical Risk Patients
- New clinical trial will assess first-of-its-kind MitraClip™ transcatheter mitral valve repair against current standard of care surgery in a new, expanded patient population 
From PR Newswire
FDA Approves Less Invasive Surgical Approach for Abbott's Heart Pump to Help Patients Avoid Open Heart Surgery
- For people battling advanced heart failure, Abbott's HeartMate 3 heart pump can now be implanted through an incision in the chest wall versus open heart surgery 
From PR Newswire
Absolute to Present at the 22nd Annual Needham Growth Conference
Absolute® (TSX:ABT), the leader in endpoint resilience, today announced that Christy Wyatt, Chief Executive Officer, will be presenting at the 22nd Annual Needham Growth Conference in New York. Joining... 
From Business Wire News Releases
Absolute Appoints Dianne Lapierre as Chief Information Officer
Absolute (TSX: ABT), the leader in endpoint resilience, today announced Dianne Lapierre has joined Absolute as Chief Information Officer. Ms. Lapierre will report directly to Absolute CEO, Christy... 
From Business Wire News Releases
Abbott Hosts Conference Call for Fourth-Quarter Earnings
Abbott (NYSE: ABT) will announce its fourth-quarter 2019 financial results on Wednesday, Jan. 22, 2020, before the market opens. 
From PR Newswire
Abbott Raises Quarterly Dividend 12.5%, Increasing Payouts for 48 Straight Years
The board of directors of Abbott (NYSE: ABT) today increased the company's quarterly common dividend to 36 cents per share – a 12.5% increase. 
From PR Newswire
Absolute Reports AGM Voting Results
Absolute Software Corporation (ABT.TO) (“Absolute”), the leader in endpoint resilience, today announced that at its annual general meeting of shareholders held on December 11, 2019, each of the six... 
From Business Wire News Releases
Abbott Announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020
- Mr. White will remain Executive Chairman of the Board 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
75 76 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.